Plasma lipidome abnormalities in people with HIV initiating antiretroviral therapy

Plasma lipidome abnormalities in people with HIV initiating antiretroviral therapy

Abstract Background Dyslipidemia often accompanies human immunodeficiency virus (HIV) infection and antiretroviral therapy (ART). Lipid abnormalities likely contribute to increased cardiometabolic disease among people with HIV (PWH). Here, we expand our previous findings on changes in the lipidome f...

Full description

Bibliographic Details
Main Authors: Emily R. Bowman, Manjusha Kulkarni, Janelle Gabriel, Xiaokui Mo, Brett Klamer, Martha Belury, Jordan E. Lake, David Zidar, Scott F. Sieg, Nehal N. Mehta, Martin P. Playford, Daniel R. Kuritzkes, Adriana Andrade, Elizabeth Koss Schmidt, Christopher Taylor, Edgar T. Overton, Amanda L. Willig, Michael M. Lederman, Nicholas T. Funderburg, the AIDS Clinical Trials Group A5248/A5249s Team
Format: Article
Language:English
Published: BMC 2020-12-01
Series:Translational Medicine Communications
Subjects:
Lipidome
HIV
Antiretroviral therapy
Inflammation
Cardiovascular disease
Online Access:https://doi.org/10.1186/s41231-020-00079-6

Internet

https://doi.org/10.1186/s41231-020-00079-6

Similar Items